Here are the DEF 14A proxy statements from BLDEW (BLDEW) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow BLDEW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BLDEW filings page.
Strata Critical Medical, Inc. calls a virtual 2026 annual stockholder meeting on May 28, 2026 at 9:00 a.m. Eastern to elect two Class II directors, ratify Deloitte & Touche LLP as auditor, and hold an advisory Say‑on‑Pay vote on 2025 executive compensation.
The company, formerly Blade Air Mobility, transformed in 2025 into a pure‑play medical logistics and services provider by selling its passenger business to Joby Aviation for approximately $76 million in Joby stock plus up to $45 million in holdbacks and earn‑outs, and acquiring Keystone Perfusion Services. It now operates Logistics and Clinical segments serving transplant and cardiovascular surgery customers.
Governance highlights include a classified Board, Co‑Chief Executive Officers William A. Heyburn and Melissa M. Tomkiel, and former CEO Robert Wiesenthal as Non‑Executive Chairman, with independent director Andrew Lauck expected to become Lead Independent Director after the meeting. The compensation program emphasizes pay for performance through cash bonuses tied mainly to Adjusted EBITDA and performance stock units.